Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders





Income Statement
Balance Sheet
Cash Flow Statement
Segments

Common Size IS
Op Efficiency
Credit Analysis

PUMA BIOTECHNOLOGY, INC. (PBYI)

Income Statement

Standardized | As Reported Annual | Quarterly | TTM
  Older >>
In millions, except per share itemsDec-31-22Dec-31-21Dec-31-20Dec-31-19Dec-31-18Dec-31-17Dec-31-16Dec-31-15
   10-K10-K10-K10-K10-K10-K10-K10-K
Total revenues  228.0253.2225.1272.3251.027.70.00.0
            Revenue growth  -9.9%12.5%-17.3%8.5%806.6%   
Cost of goods sold  55.163.739.436.834.65.60.00.0
Gross profit  172.9189.5185.7235.4216.422.10.00.0
            Gross margin  75.8%74.8%82.5%86.5%86.2%79.9%  
Selling, general and administrative  90.0116.3118.5141.6146.2106.753.831.8
Research and development  52.271.997.7132.9164.9207.8222.8208.5
EBITDA   [+]39.611.9-20.4-31.0-87.3-289.6-275.4-239.5
            EBITDA margin  17.4%4.7%-9.0%-11.4%-34.8%-1046.0%  
Depreciation  0.92.63.74.23.51.21.10.8
EBITA  38.79.3-24.1-35.1-90.8-290.8-276.6-240.3
            EBITA margin  17.0%3.7%-10.7%-12.9%-36.2%-1050.4%  
Amortization of intangibles  8.08.06.33.93.91.6  
EBIT   [+]30.71.3-30.4-39.0-94.7-292.4-276.6-240.3
            EBIT margin  13.5%0.5%-13.5%-14.3%-37.7%-1056.1%  
Non-recurring items   [+]7.0       
Interest expense, net   [+]10.812.613.612.29.2-0.5-1.0-1.0
Other income (expense), net   [+]-12.5-17.4-15.8-24.3-9.7-0.1-0.40.0
Pre-tax income  0.5-28.8-59.8-75.5-113.6-292.0-276.0-239.3
Income taxes  0.50.30.20.10.00.00.00.0
            Tax rate  99.6%    0.0%0.0%0.0%
Net income  0.0-29.1-60.0-75.6-113.6-292.0-276.0-239.3
            Net margin  0.0%-11.5%-26.7%-27.8%-45.3%-1054.6%  
   
Basic EPS   [+]$0.00($0.72)($1.52)($1.95)($2.99)($7.85)($8.29)($7.45)
Diluted EPS   [+]$0.00($0.72)($1.52)($1.95)($2.99)($7.85)($8.29)($7.45)
   
Shares outstanding (basic)   [+]44.740.639.638.837.937.233.332.1
Shares outstanding (diluted)   [+]44.940.639.638.837.937.233.332.1
   
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges.  

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy